NCT03222596

Brief Summary

The most common symptom displayed in patients with multiple sclerosis (MS) is a pronounced sense of fatigue that can have negative effect on functional ability and quality of life (QOL). An important goal of researchers and clinicians involves improving the QOL of individuals with MS, and the exercise therapy represents potentially modifiable behavior that positively impacts on pathogenesis of MS and thus the QOL. However, the main barrier for its application is low motivational level that MS patients experience due to fatigue with adjacent reduced exercise tolerability and mobility, and muscle weakness. Getting individuals with MS motivated to engage in continuous physical activity may be particularly difficult and challenging, especially those with severe disability or Expanded Disability Status Scale (EDSS 6-8). Till now, researchers have focused their attention mainly on the moderate or vigorous intensity of exercise and on cardiorespiratory training in MS patients to achieve improvements in daily life quality, less indicating the exercise content, and most importantly, breathing exercises. In addition, it is investigators intention to make exercise for MS patients more applicable and accessible, motivational and easier, but most important, productive. Investigators think that MS patients experience more stress with aerobic exercise or moderate to high intensity programme exercise, and can hardly keep continuum including endurance exercise, or treadmill. Hypothesis: Investigators hypothesis is that 4-weeks of continuous low demanding or mild exercise programme with specific content and an accent on breathing exercise can attenuate primary fatigue in MS patients, especially in those with more severe disability or EDSS from 6-8, and provide maintenance of exercise motivation. Investigators also propose that important assistant factor for final goal achievement is social and mental support of the exercise group (EDSS from 0-8) led by a physiotherapist. This will help to maintain exercise motivation and finally make better psychophysical functioning, and thus better QOL.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2017

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 16, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 19, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2017

Completed
Last Updated

January 2, 2019

Status Verified

December 1, 2018

Enrollment Period

2 months

First QC Date

July 16, 2017

Last Update Submit

December 29, 2018

Conditions

Keywords

Quality of LifeFatiguePhysical DisabilityDisabilities PsychologicalPainMotivationMultiple sclerosis

Outcome Measures

Primary Outcomes (7)

  • Change of fatigue intensity

    Fatigue estimation using the "Modified Fatigue Impact Scale" (MFIS)

    baseline, after 4 weeks

  • Change of pain intensity

    Assessment of pain level using a "Visual Analogue Scale" (VAS) for pain

    baseline, after 4 weeks

  • Motivation.

    Survey made from questions for subjective self-evaluation of motivation efficiency.

    baseline, after 4 weeks

  • Change of physical abilities and limitations.

    Assessment of the functional independence of daily activities and severity of individuals disability using the "Barthell Index".

    baseline, after 4 weeks

  • Change of mental abilities and limitations.

    Assessment of cognitive ability using the "Standardized Mini-Mental State Examination" test (SMMSE).

    baseline

  • Change of quality of life.

    Evaluation of Quality of Life using the abbreviated version of the "36-Item Short Form Survey" (36-SF) including physical function, role of constraints due to physical problems, physical pain, general health perception, energy level, social function, the role of limitations due to psychological problems and general mental health.

    baseline, after 4 weeks.

  • Change of grip strength.

    Grip strength testing using hand hydraulic dynamometer.

    baseline, after 4 weeks

Study Arms (2)

Multiple Sclerosis Exercise

EXPERIMENTAL

Ambulatory and non-ambulatory MS individuals that will exercise-group (MSE). Intervention is exercise training.

Behavioral: Exercise training

Multiple Sclerosis Control (no-Exercise)

NO INTERVENTION

Ambulatory and non-ambulatory MS individuals that will not exercise-group (MSC).

Interventions

Exercise programme includes breathing and upper limbs exercises.

Multiple Sclerosis Exercise

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with multiple sclerosis (EDSS 0-8)
  • Ambulatory and non-ambulatory (in wheelchairs)

You may not qualify if:

  • Individuals with contraindications for exercising
  • Individuals with multiple sclerosis with EDSS over 8

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of physiology and immunology, Medical Faculty, University of Rijeka

Rijeka, Primorje-Gorski Kotar County, 51000, Croatia

Location

MeSH Terms

Conditions

Multiple SclerosisFatigueMotor ActivityPain

Interventions

Exercise

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorNeurologic Manifestations

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Tanja Grubić Kezele, PhD, MD

    Biomedicine investigations

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomly selected into 2 groups: ambulatory and non-ambulatory (wheelchair) MS individuals that will exercise - group (MSE), with related control group (ambulatory and non-ambulatory (wheelchair) individuals who will not exercise) (MSC). In addition, a group of healthy control subjects without MS (HC) will be evaluated. Ambulatory and non-ambulatory group of individuals will exercise under the guidance of a physiotherapist.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, MD

Study Record Dates

First Submitted

July 16, 2017

First Posted

July 19, 2017

Study Start

July 14, 2017

Primary Completion

August 28, 2017

Study Completion

August 28, 2017

Last Updated

January 2, 2019

Record last verified: 2018-12

Locations